Dec 20, 2025
Most ViewedWhich new drugs for peripheral neuropathy received FDA fast-track or breakthrough designations in 2024–2025?
Two relevant regulatory moves in 2024–2025 implicate drugs and devices aimed at peripheral neuropathies, but only one — Sangamo’s investigational gene‑regulating candidate ST‑503 — is explicitly docum...